Ming Hou, Dr
Shandong University
6
6
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (6)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Ming Hou, Dr.
Shandong University
Shared therapeutic areas:
Worked with same sponsors:
Thomas Ortel, MD
Duke University
Shared therapeutic areas:
James Bussel, MD
Weill Medical College, Cornell University
Shared therapeutic areas:
Nigel Key, MD
University of North Carolina, Chapel Hill
Shared therapeutic areas:
Xiaohui Zhang, md
Peking University People's Hospital, Peking University Insititute of Hematology
Shared therapeutic areas:
Mohsen S Elalfy, professor
Ain Shams University
Shared therapeutic areas:
James George, MD
The University of Oklahoma
Shared therapeutic areas:
heng Mei
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Shared therapeutic areas:
Jodi Segal, MD
Johns Hopkins University
Shared therapeutic areas:
Joseph Kiss, MD
University of Pittsburgh
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (6)
Showing 6 of 6 trials
The Study of Different Dose Rituximab in the Treatment of ITP
All-Trans Retinoic Acid (ATRA) Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
An Investigation of rhTPO With Different Frequencies in the Management of ITP
Decitabine Combining Dexamethasone Versus Dexamethasone in Management of ITP
Rituximab Combining Bortezomib Versus Rituximab in Management of ITP
Atorvastatin in Management of Newly Diagnosed ITP
All 6 trials loaded